Prevalence of hypertension and associated cardiovascular risk factors in an urban slum in Nairobi, Kenya: A population-based survey by unknown
Joshi et al. BMC Public Health 2014, 14:1177
http://www.biomedcentral.com/1471-2458/14/1177RESEARCH ARTICLE Open AccessPrevalence of hypertension and associated
cardiovascular risk factors in an urban slum in
Nairobi, Kenya: A population-based survey
Mark David Joshi1*, Richard Ayah2, Elijah Kaharo Njau1, Rosemary Wanjiru1, Joshua Kyateesa Kayima1,
Erastus Kennedy Njeru2 and Kenneth Kipyegon Mutai3Abstract
Background: Urbanisation has been described as a key driver of the evolving non-communicable disease (NCD)
epidemic. In Africa, hypertension is the commonest cardiovascular problem. We determined the prevalence and risk
factor correlates of hypertension in the largest Nairobi slum.
Methods: In 2010 we conducted a population-based household survey in Kibera, a large informal settlement in
Nairobi City; utilising cluster sampling with probability proportional to size. Households were selected using a
random walk method. The WHO instrument for stepwise surveillance (STEPS) of chronic disease risk factors was
administered by trained medical assistants, who also recorded blood pressure (BP) and anthropometric measures. BP
was recorded using a mercury sphygmomanometer utilising the American Heart Association guidelines. Hypertension
was defined as per the 7th Report of the Joint National Committee or use of prescribed antihypertensive medication.
Those with hypertension or with random capillary blood sugar (RCBS) >11.1 mmol/l had an 8 hours fasting venous
blood sugar sample drawn. Age standardised prevalence was computed and multivariate analysis to assess
associations.
Results: We screened 2200 and enrolled 2061 adults; 50.9% were males; mean age was 33.4 years and 87% had
primary level education. The age-standardised prevalence of hypertension (95% CI) was 22.8% (20.7, 24.9). 20%
(53/258) were aware of their hypertensive status; 59.3% had pre-hypertension; 80% reported high levels of physical
activity and 52% were classified as harmful alcohol drinkers; 10% were current smokers and 5% had diabetes. Majority
of males had normal BMI and waist circumference, whereas a third of females were obese or overweight and 40% had
central obesity. Older age, higher general and central obesity were independently associated with hypertension and
higher SBP and DBP readings.
Conclusions: Our findings of high prevalence of hypertension, in association with excess body weight in this poor
urban slum community, point to the need for greater awareness and implementation of primary preventive strategies.
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The prevalence of Non-Communicable Diseases (NCD) in
low- and middle-income countries is rising rapidly [1].
Half of the current health burden in developing nations is
attributable to non-communicable diseases [2]. By 2020 it
is projected that non-communicable diseases including,
hypertension, will outstrip communicable diseases as the
leading cause of death. Demographic changes, increasing
urbanization and lifestyle changes are some of the factors
contributing to the increasing burden of NCD [3].
Hypertension is a major contributor to NCD burden
in both developed and developing countries [4]. Hyper-
tension is a primary cause of haemorrhagic and athero-
thrombotic stroke, hypertensive heart disease, hypertensive
kidney failure, coronary artery disease [5,6].
Hypertension is now the most common cardiovascular
problem in Africa, and it is estimated that more than 20
million people are affected [7]. In sub-Saharan Africa
hypertensive end organ damage is a major source of mor-
bidity and mortality [6]. The reported prevalence of hyper-
tension in Africa ranges from 25% to 35% in adults aged
25 to 64 years [7], and increases with advancing age. A re-
cent study of urban and rural Tanzania reported rates of
stroke mortality higher than those of England and Wales,
and suggested that untreated hypertension is an important
etiological risk factor [8]. In Kenya there is a paucity of
data on hypertension prevalence, and at the time of our
survey in 2010 only two studies had been reported. The
initial 1986 survey was undertaken in a regional centre,
among both rural and urban residents, reported non-
standardised hypertension prevalence of 6.4% [9]. A 2008
regional cross-sectional study, restricted to subjects aged
over 50 yr and conducted in predominantly rural popula-
tion, reported a prevalence of 50.1% [10].
Urbanisation is a key driver of the evolving NCD epi-
demic in developing countries [3]. In Kenya 22.3% of the
population is urban, with an urban population growth
rate of 4.2% almost double the national population
growth rate of 2.4% [11]. In the capital city Nairobi, a
majority (60%) of the population live in slums with much
of the migrant population settling in slums. Furthermore
75% of the urban population growth is absorbed by infor-
mal settlements. To address the data void on the burden
of hypertension in Kenya, we report on the prevalence
and risk factor correlates of hypertension, in a representa-
tive sample of the rapidly expanding urban poor segment
of our population.
Methods
The urban slum of Kibera in Nairobi, the capital of Kenya
was chosen as the study area. Kibera is located 5 km
southwest of Nairobi city centre and is approximately
2.5 square kilometres, with an estimated 300,000 in-
habitants [11]. This study was conducted using UNrecommendation for cluster sampling with probability
proportional to size adjusted to achieve our sample size
[12]. A design effect of 2.0 was used to account for the
clustering of the study participants. A sampling frame
with the list of villages and the projected populations of
each was obtained. As a result a total of 80 clusters
each containing 10 households and thus 25 participants
per cluster were created within the eight villages with
the number of clusters proportional to the population
size within the particular village. The households in
each cluster were visited in a random walk method from
the nearest health centre, church or school as the focal
point in each cluster. Within each household, all consent-
ing adults of 18 years and above, who had been residents
of the area for more than 3 months, were enrolled. Exclu-
sions included those under the age of 18 years; non-
consenting individual and pregnant women. The next
household was taken as the one nearest to that previously
visited until the sample size for the given cluster was
achieved. The WHO STEPS-wise approach for collecting
surveillance data for non-communicable diseases (NCD’s)
was adopted to collect data. The WHO STEP-wise ap-
proach to surveillance of non-communicable diseases is a
validated instrument developed by WHO for collection of
surveillance data on NCD’s in resource poor settings. It is
a sequential process made up of three main sections,
which are the risk stratification questionnaire (step1),
anthropometric measurements (step 2) and biochemical
measurements (step3) [13].
The survey was conducted between June and August
2010 with research teams visiting selected household be-
tween 8 am and 4 pm daily on weekdays. We minimized
missing respondents by making a maximum of two re-
visits on subsequent Sundays. The questionnaire was ad-
ministered by study trained registered medical assistant
teams supervised by a study medical doctor. The ques-
tionnaire covered the smoking habits, alcohol use and
physical activity pattern, history of prior evaluation for
diabetes and hypertension, and if any, the medication
and lifestyle counselling that had been given. Anthropo-
metric measures were recorded as hereunder. Height
was measured to the nearest 0.5 cm using a metal meas-
uring tape against a wall and a flat headboard at right
angles to the wall. Weight was measured to the nearest
100gms using a good quality bathroom scale (Ashton
Meyers®) with the subject in light clothing and without
shoes. Mid upper arm circumference was measured to
the nearest 0.5 cm. Waist circumference was taken with
a flexible tape measure placed on a horizontal plane at
the level midpoint between the superior border of the
iliac crest and the inferior margin of the last rib mid-
axillary plane and the recording was at the end of nor-
mal expiration. Hip circumference was measured at the
widest level over the greater trochanter. Body mass index
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body obesity while waist circumference and waist hip ratio
was used as measures of abdominal obesity. Body mass
index (BMI) < 18.5 was recorded as underweight, 18.5-
24.9 as normal, 25–29.9 as overweight and BMI more
than 30 was recorded as obesity. Significant waist circum-
ference was recorded as more than 102 cm (40 inches) for
males and more than 88 cm (35 inches) in females. Signifi-
cant waist to hip ratio was considered abnormal in females
with a ratio of >0.8 and males >0.9 [14].
Blood pressure was recorded using a mercury sphygmo-
manometer (Riester; Jungingen Germany) after the risk
factor questionnaire had been filled to ensure that subjects
had been seated for at least fifteen minutes. American
Heart Association guidelines for measuring blood pressure
were used [15]. Three intermittent brachial cuff readings
were taken and an average obtained. A random capillary
blood sugar (RCBS) was recorded using a glucometer. Par-
ticipants who had a RCBS >11.1 mmol/l and those with
hypertension as per study definition were invited to
present themselves to the nearest health facility at a later
designated date after an minimal 8 hours overnight fast. A
fasting specimen of 5mls blood was drawn from a peri-
pheral vein, preferably the ante-cubital fossa for venous
fasting blood sugar (FBS) analysis.
Research assistants underwent training on how to
complete the STEPS questionnaire and on anthropomet-
ric and blood pressure measurements to ensure standar-
dization. The sphygmomanometers, weighing scales and
tape measures were assessed weekly by taking measure-
ments of one person on each of the instruments to en-
sure they were standardized. Recommended procedures
for specimen collection, preparation and storage were
followed to minimize pre-analytical errors. Before ana-
lysis, all the assays were calibrated according to the
manufacturer’s specifications. Commercial controls used
to validate the calibrations. Results were transcribed
onto data sheets, which were checked by two people to
minimize post analytical transcriptional errors.
Hypertension was defined and classified as per the
Seventh Report of the Joint National Committee [16] on
prevention, detection and treatment of high blood pres-
sure as being systolic BP > = 140 mmHg and/or diastolic
BP > = 90 mmHg or use of prescribed antihypertensive
medication. Hypertension was classified into pre-hyper-
tension, stage 1 or 2 hypertension as per JNC VII. If the
systolic and diastolic pressure readings belonged to dif-
ferent categories, the higher of the two readings was
used to assign the blood-pressure stage. Isolated Systolic
and Isolated Diastolic Hypertension was defined as per
the specified BP cut-offs but with only one category ele-
vated. Participant were diagnosed with diabetes if they
had a RCBS level of > = 11.1 mmol/l and a venous FBS
of > = 7.0 mmol/l, or had been diagnosed with diabetesor were receiving treatment for diabetes with insulin or
oral hypoglycaemic agents. As per the STEPs instrument
physical activity (PA) domains and the Global Physical
Activity (GPAQ) analysis guide [17], categorical PA
levels was coded based on total days and duration of PA
and as Total PA in metabolic equivalents of task (METs)
minutes per week. Total PA was classified as follows:
high as >3000 MET-minutes per week; moderate as 600–
3000 MET-minutes per week and low as <600 MET-
minutes per week.
Statistical analysis was undertaken using Statistical
Products and Service Solutions (SPSS for Windows Ver.
16.0 Chicago, SPSS Inc). Prevalence was age standardised
utilising the new WHO World Standard population, direct
standardisation method [18]. Associations between the
subjects socio-demographic, clinical and laboratory char-
acteristics were examined using chi-square test for the
categorical data while for the continuous variables the
Student t-test was used to determine statistical signifi-
cance and Mann Whitney U test used in the analysis
where such continuous data is skewed.
Adjusted odds ratios (OR) for the association between
hypertension and body mass indices and diabetes were
computed with 95% CIs. Binary logistic regression was
used to adjust for odds of hypertension associated with s
body mass indices and diabetes and the results expressed
as OR with 95% confidence intervals (CIs). Multiple
linear regression was used to analyse of predictors of ele-
vated systolic and diastolic BP and results expressed as a
beta coefficients with 95% CI. Associations were consi-
dered significant at the conventional value of p value less
than or equal to 0.05.
Ethical considerations
Study approval was obtained from the Kenyatta National
Hospital (KNH) Ethics and Research Committee and the
Ministry of Science and Technology. Administrative per-
mission was obtained from the Nairobi City Council and
the provincial administration and Kibera community
leaders and elders were informed of the study. Verbal con-
sent from head of household and written consent from all
eligible adults over the age of 18 yrs was obtained. Follow
up care for clinical conditions detected was facilitated
by referral to KNH and Mbagathi district Hospital as
appropriate.
Results
We screened 2200 eligible adults from 936 households
in eight villages, excluded 139 (38 pregnant women, 50
declined consent and 51 below 18 yrs. of age) and thus
enrolled 2061 subjects, representing a 98% response rate.
An average of 2.4 adults per household was surveyed. At
analysis complete data was available in 2045 subjects with
males comprising 50.9%.
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age of 33.4 yrs. (SD 11.6 yrs.); 53.9% were aged 25–44 years,
28.3% were under 25 years and 5.2% were 55 years or older.
Literacy level was high with 87% having either a primary or
secondary level of educational attainment.
Demographics and behavioural risk factors of the
study sample are depicted in Table 1. Current cigarette
smokers comprised 13.1%, 84.8% of whom were daily
smokers. Alcohol consumption was high with 30% re-
ported to have ever consumed alcohol; 81% of whom
consumed alcohol in the previous twelve months with a
consumption frequency of 19.1% on a daily basis and 52%
between 1–6 days per week; the average and largest num-
ber of drinks per sitting being four and six respectfully.
Physical activity
Study subjects demonstrated a high level of physical ac-
tivity (PA) that was predominantly work and travel re-
lated. Vigorous or moderate work related activity was
undertaken by 75.7% (male 78.2%, female 73%), at a me-
dian duration of 7 hrs for 6 days per week. Walking or
cycling as mode of transport was undertaken by 77.4%
(male 80.3%, female 74.3%) for a median duration of one
hour for 6 days per week. Vigorous work related PA was
more common in males whereas moderate work related
PA was more common in females. (Table 1) Physical ac-
tivity data in metabolic equivalents (METS) was available
for 87.9% (n 1797) of sample. The median (IQR) total
physical activity (PA) in MET-minutes per week was
10800 (3840, 21120) for the entire sample and 13474
(5040, 24960) among males and 8400 (3168, 15630)
among females (Table 1). This was indicative of a very
high level of total PA in both genders; with 80.2% re-
cording high (>3000) and 17.5% recording moderate
(600 to 3000) level of total PA in METs minutes per
week.
Body mass index
Mean (95% CI) Body Mass Index (BMI) was 24.2 (23.9,
24.6) in males and 27.1 (26.6, 27.6) in females (P =
0.000). BMI increased with age in both genders. Major-
ity of males had a normal BMI. However among
females 32.2% were overweight (BMI >25%), 26.1%
were obese and 38.5% had a normal BMI; thus 58.3% of
women were either obese or over-weight. Prevalence of
over-weight (BMI >25-29.9) and obesity (BMI ≥30)
were significantly higher among women (P = 0.0001 for
both BMI categories). Only 5.8% of men and 3.1% of
females were underweight.
Waist circumference
Mean (95% CI) waist circumference (WC) was 81.9 cm
(81.3, 82.6) in males and 86.6 cm (85.6, 87.5) in females.
WC increased with age in both sexes; however 97.4% ofmales had a normal WC. The prevalence (95% CI) of WC
defined central obesity (WC >88 cm in females & > 108 cm
in males) was 41.5% in females and 2.6% in males (P =
0.001).
Waist-hip ratio
Mean (95% CI) waist-hip ratio (WHR) was 0.89 (0.87,
0.92) in males and 0.85 (0.84, 0.87) in females. Majority of
both genders had normal waist-hip ratio (WHR), however
24% of women had an elevated WHR (WHR >0.80) and
the prevalence of central obesity as defined by WHR was
significantly higher among females (P = 0.001 ). All mea-
sures of body mass showed a statistically significant in-
crease with age among females (P = 0.000); and the same
were evident among male subjects (P = 0.000) except for
WHR that did not show a statistically significant increase
with age (P = 0.269).
Blood pressure
The crude prevalence (95% CI) of hypertension (BP ≥ 140/
90 mmHg or taking prescribed antihypertensive medica-
tion) was 12.6% (11.2, 14.1); 11.7% (9.7, 13.6) in males
and 13.7% (11.5, 15.8) in females (P = 0.166). Prevalence
increased with age and was significantly higher among
females in the age strata of 35–44 yrs. (p = 0.008) and 55-
64 yrs (P = 0.001) (Figure 1). The new WHO Standard
population age standardised prevalence of hypertension
(95% CI) was 22.8% (20.7, 24.9) in the entire sample and
23.2% (20.4, 26.1) in analysis restricted to those over
35 years of age. Only 20% (53/258) were aware of their
hypertensive status and among the known and drug
treated hypertensive subjects 49% (26/53) had controlled
hypertension at time of survey (BP < = 140/90 mmHg.).
Only 30.9% (631/2045) of study subjects reported ever
having had a BP measured by health workers and 22.3%
(141/631) having been told that their BP was elevated;
95.7% (135/141) having been informed so in the twelve
months prior to interview. Of those informed of an ele-
vated BP in the past year 39.5% (53/135) had been pre-
scribed antihypertensive therapy and were on the therapy
in the two weeks prior to interview. The proportions ad-
vised on non-pharmacological measures for BP control
were: 40% salt restriction, 28.9% increased physical activ-
ity, 25.2% weight reduction and 17% smoking cessation.
Regarding alternative therapies 17% had ever seen a trad-
itional healer and 11.9% were on current herbal or trad-
itional remedies for the treatment of raised BP.
The mean (95% CI) systolic blood pressure (SBP)
among males and females was 124 mmHg (123.1, 124.8)
and 123.5 mmHg (122.7, 124.4) respectively. The mean
(95% CI) diastolic blood pressure (DBP) among males
and females was 77.5 mmHg (76.9, 78.1) and 76.9 mmHg
(76.2, 77.5) respectively. SBP & DBP increased with age
in both sexes, with no gender differential. For both SBP
Table 1 Demographic and behavioural risk factors across sex and hypertensive status
Overall % (n) Male % (n) Female % (n) P value † Hypertensive Normotensive P value‡
Age yrs
18-24 28.3 (578) 27.7 (291) 28.8 (287) 0.051
25-34 31.8 (651) 30.1 (316) 33.7 (335)
35-44 22.1 (452) 22.2 (233) 22.0 (219)
45-54 12.5 (256) 13.7 (144) 11.3 (112)
55-64 3.8 (78) 4.8 (50) 2.8 (28)
65-74 1.2 (25) 1.4 (15) 1.0 (10)
≥ 75 0.2 (5) 0.1 (1) 0.4 (4)
18-90 100 (2045) 51.0 (1050) 48.4 (995)
Years in school, mean (SD) 9.3 (3.3) 9.8 (3.2) 8.7 (3.2) 0.000
Tobacco smoking
Current % (n) 13.1 (269) 22 (231) 3.8 (38) 0.000 17.8 (46) 12.5 (223) 0.018
Smoking daily % (n) 84.8 (228) 89.2 (206) 57.9 (22) 0.000 82.6 (38) 85.2 (190) 0.656
Age started yrs mean (SD) 19.7 (5.5) 19.9 (5.7) 18.6 (3.4) 0.304 21.5 (6.8) 19.4 (5.2) 0.037
Age started range yrs 10-45 10-45 10-24 - - - -
Duration years mean (SD) 16.5 (10) 16.4 (10.2) 17.3 (9.1) 0.696 21.4 (11.3) 15.4 (9.5) 0.001
Pack years median (Q1-Q3) 6 (2.5-10.9) 6 (2.4-10.5) 7.5 (4.4-12.0) 0.303 8.3 (3.9-13.8) 6.0 (2.4-10.5) 0.058
Alcohol consumption
Ever consumed 30.1 (616) 43.2 (454) 16.3(162) 0.000 33.3 (86) 29.7 (529) 0.233
In past 12 months 81.0 (499) 89.6 (407) 56.8 (92) 0.000 76.7 (66) 81.7 (432) 0.281
In past 30 days 76.8 (383) 79.1 (322) 66.3 (61) 0.009 75.8 (50) 77.1 (333) 0.812
Frequency in past 12 months
Daily 19.1 (95) 22.1 (90) 5.5 (5) 0.008 25.8 (17) 18.1 (78) 0.180
5-6 days/week 14.3 (71) 13.8 (56) 16.5 (15) 7.6 (5) 15.3 (66)
1-4 days/week 28.7 (143) 27.0 (110) 36.3 (33) 28.8 (19) 28.7 (124)
1-3 days/week 23.3 (116) 22.9 (93) 25.3 (23) 18.2 (12) 24.1 (104)
Average number of drinks median
(Q1-Q3)
4 (3–6) 4 (3–6) 3 (2–5) 0.087 4 (4–5) 4 (3–6) 0.272
Largest number of drinks/sitting 6 (4.5-9) 6 (5–9) 6 (4–7) 0.026 6 (3–8.5) 6 (5–9) 0.178
Physical Activity
Work Vigorous 29.6 (606) 39.1 (411) 19.6 (195) 0.000 24.4 (63) 30.5 (543) 0.050
Days/week median (Q1-Q3) 6 (5–7) 6 (5–7) 6 (3–7) 0.537 6 (5–7) 6 (5–7) 0.116
Hours/day median (Q1-Q3) 8 (3–9) 8 (4–9) 6 (2–8) 0.000 8 (3–9) 8 (4–9) 0.877
Work moderate 46.1 (943) 39.1 (411) 53.4 (532) 0.000 43.0 (111) 46.6 (830) 0.295
Days/week median (Q1-Q3) 6 (5–7) 6 (4–7) 7 (5–7) 0.000 6 (5–7) 6 (5–7) 0.420
Hours/day median (Q1-Q3) 6 (3–8) 6 (3–8) 5 (2.1-8.0) 0.000 8 (3–10) 6 (3–8) 0.016
Travel (walk/cycle) 77.4 (1583) 80.3 (843) 74.3 (740) 0.001 70.2 (181) 78.5 (1399) 0.003
Days/week median (Q1-Q3) 6 (5–7) 6 (5–7) 6 (4–7) 0.001 6 (5–7) 6 (5–7) 0.148
Hours/day median (Q1-Q3) 1 (0.75-2) 1.3 (0.8-2.0) 1 (0.7-2.0) 0.023 1.3 (0.5-3) 1.0 (0.8-2) 0.480
Recreational vigorous 15.2 (311) 21.7 (228) 8.3 (83) 0.000 12.0 (31) 15.7 (280) 0.127
Days/week median (Q1-Q3) 2.0 (1–3) 2.0 (1.0-3.0) 2 (1–3) 0.737 2 (1–5) 2 (1–3) 0.603
Hours/day median (Q1-Q3) 2.0 (0.8-2) 2.0 (1.0-2.0) 1.4 (1–2) 0.142 1.2 (0.5-2) 1.5 (1–2) 0.165
Recreational moderate 16.4 (336) 16.9 (177) 16 (159) 0.586 10.5 (27) 17.3 (309) 0.006
Days/week median (Q1-Q3) 3 (1–6) 3.0 (1.0-6.0) 3 (1–6) 0.986 4 (2–7) 3 (1–6) 0.214
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Table 1 Demographic and behavioural risk factors across sex and hypertensive status (Continued)
Hours/day median (Q1-Q3) 1 (0.7-2) 1.5 (0.8-2.0) 1 (0.7-2) 0.058 2 (0.5-2) 1 (0.8-2) 0.776
Time sitting/reclining hrs mean
(range)+
4 (2–6) 4.0 (2–6) 4 (2–7) 0.004 5 (2.5-8.0) 4 (2–6) 0.001











+Hours per day; sleeping time not included; *METs =metabolic equivalent minutes per week; Q1-Q3 = inter-quartile range; SD = standard deviation.
†P value for sex comparison. ‡P value for Hypertensive status comparison.
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strata and higher reading in the older age strata, with
the transition occurring in the 35-44 yr age strata.
Among those subject with screening detected blood
pressure, that was higher than JNC defined optimal blood
pressure (BP >120/80 mmHg) (i.e. excluding those with
known hypertension and or on treatment), 59.3% had pre-
hypertension (61.8% male; 56.6% females) and 6.2% had
Stage 1 and 4.1% Stage 2 Hypertension (Table 2).
In the entire sample, the crude prevalence (95% CI) of
Isolated Systolic Hypertension (ISH) and Isolated Dia-
stolic Hypertension (IDH) was 1.6% (1.1, 2.2); [males 1.5%
(0.8, 2.2) females 1.8% (1.2,2.7)], and 2.7% (2.0, 3.4) [males
2.9% (1.9, 4.1) females 2.5% (1.6, 3.5)] respectively. The
combined prevalence of ISH and IDH in the entire sample
was 6.0% (4.9, 7.0); 5.9% (4.1, 7.4) in males and 6.1% (4.6,
7.7) in females. The age strata of 55–64 yrs. demonstrated
a higher female prevalence of high blood pressure and
combined systolic and diastolic hypertension (Additional
file 1). Additional file 2 depicts the crude prevalence
of high blood pressure and isolated forms of hyperten-
sion in those with high blood pressure (ie excluding
subjects with known hypertension and on treatment at
survey).Figure 1 Prevalence of hypertension across age and sex.Risk factors distribution by hypertension status
Behavioural cardiovascular risk factors distribution by
hypertensive status are depicted in Table 1. Compared to
normotensive, a larger proportion of hypertensive sub-
jects were current Smokers (17.8%; 12.5%; P = 0.018),
had commenced smoking at older age (21.4 yrs.; 15.4 yrs;
P = 0.037) and had a longer duration of smoking (8.3 yrs,
6.0 yrs, P = 0.001). Alcohol consumption levels among hy-
pertensives was high and equal to that of normotensives
and the entire sample. Hypertensives demonstrated a
similar pattern of high level of physical activity (PA) as
normotensives. The median total PA (Q1-Q3)) in MET-
minute per week in hypertensive subjects was 11520
(3840, 21110) and 10630 (3840, 21120) in normotensive
subjects (P = 0.998).
Categories of body mass indices stratified on hyperten-
sive status are depicted in Table 3. Compared to normo-
tensive, the age, sex and alcohol adjusted OR (95% CI) of
a hypertensive being obese was 2.9 (1.9, 4.4), of being
over-weight 1.8 (1.2, 2.5) and of having waistline defined
central obesity 2.4 (1.6, .6); with no significant gender dif-
ferences. An elevated waist–hip ratio was not significantly
associated with an increased likelihood of hypertension
(OR 1.3; 95% CI 0.8, 2.0).The proportion of hypertensive
Table 2 Prevalence of hypertension, high blood pressure,









Yes 258 (12.6) 122 (11.6) 136 (13.7) 0.165
No 1787 (87.4) 928 (88.4) 859 (86.3)
Blood Pressure
Normal 604 (30.4) 288 (27.9) 316 (33.1) 0.073
Pre-Hypertension 1178 (59.3) 637 (61.8) 541 (56.6)
High Blood Pressure* 205 (10.3) 106 (10.3) 99 (10.4)
Stage 1 124 (6.2) 65 (6.3) 59 (6.2)
Stage 2 81 (4.1) 41 (4.0) 40 (4.2)
*High Blood Pressure category excludes subjects known to be hypertensive
and on treatment at survey.
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to normotensive, hypertensive subjects were 4.4-fold (95%
CI 2.4-8.3) more likely to have diabetes. The odds of a
female hypertensive having diabetes was 2.9 fold (95% CI
1.0, 8.3) that of a male hypertensive though this was of
borderline statistical significance (P = 0.049). The odds of
diabetes in the normotensive did not demonstrate a gen-
der propensity.
In a multivariable linear regression model, the associ-
ation between age and WC with blood pressure (BP)
showed that per decade increase in age SBP increased by
2.6 mmHg (1.86 mmHg males; 3.6 mmHg females) and
DBP increased by 2.2 mmHg (1.6 mmHg males;
3.0 mmHg females).Similarly per five centimetre in-
crease in WC, SBP increased by0.50 mmHg (0.78 mm
Hg males & 0.35 mmHg females) and DBP increased by
0.40 mmHg (0.56 mmHg male; 0.32 mmHg females).
Per unit increase in BMI, SBP increased by 0.2 mmHg in
both gender, and DBP increased by 0.08 mmHg
(0.12 mmHg males, 0.06 mmHg females).
Discussion
This study of adults living in the largest urban slum in
Kenya shows high age adjusted prevalence of hyperten-
sion with close to quarter (23%) classified as hyperten-
sive and 60% as pre-hypertensive. Majority (80%) were
undetected and only one in three study subjects had ever
undergone blood pressure screening suggesting a low
overall awareness of hypertension. Hypertension preva-
lence increased with age and tended to be higher in
women in the older age categories. Our reported hyper-
tension prevalence is consistent with that of recently
published reports in rural and urban non-slum African
studies [19-21]. Studies on the prevalence of hyperten-
sion in Kenya are sparse and until recently none had
been undertaken among slum residents [8,9,22]. A 2011
report from Old Town Mombasa reports an adjustedprevalence of 32% [22]. No regional studies have been
undertaken among slum dwellers. Two studies in Kenya
have reported on hypertension among poor urban slum
residents [23,24]. Of these one was among a non-
probability sample of Kibera slum resident and reported
an unadjusted hypertension prevalence of 13% [24]. The
other utilised cluster sampling and reported a WHO
standardised population prevalence of 18.4%, inclusive of
an 80% screen detection rate [23].
Our study subjects were homogeneous with regards to
high levels of travel or work related physical activity and
important high levels of harmful alcohol intake. Ten per-
cent were current smokers. Majority of males had a nor-
mal body mass measurement, however females showed a
high prevalence of excess body mass with one-third be-
ing obese or overweight and 40% having central obesity.
Correlates of hypertension included advancing age,
overweight, general and central obesity which were asso-
ciated with 2–3 fold increased likelihood of hyperten-
sion, affirming that these are risk factor for development
of primary hypertension in this population. These asso-
ciations are well established and have been described in
SSA [21], and in particular were similarly demonstrated
in a recent Nairobi slum survey report [23].
One out of every seven hypertensive was found to be
diabetic with an almost five fold likelihood of a hyper-
tensive being diabetic. In a related publication we re-
ported age adjusted diabetes prevalence of 5%, with one
in two persons with diabetes being hypertensive and a
threefold likelihood of person with diabetes being hyper-
tensive [25]. The association between these cardiovascu-
lar NCD risk factors of diabetes and hypertension is well
established, and compounds total cardiovascular risk
[26]. This finding points to the possibility of using blood
pressure measurement as a first step in cardiovascular
non-communicable disease screening in community and
resource poor settings.
Our findings of high prevalence of predominantly un-
detected hypertension and pre-hypertension in associ-
ation with behavioural/physiological risk factors (of
alcohol and high body weight and diabetes) in this poor
urban slum community, with high levels of physical ac-
tivity, point to an early social transition of cardiovascular
disease in the urban poor and the need for primary and
secondary prevention strategies through lifestyle inter-
ventions. Furthermore an increased and sustained
awareness of the burden of hypertension among the
public and health personnel is required. This will assist
in the detection, treatment and control of hypertension
and associated risk factors.
A detailed study of the dietary practises contributing
to excess body weight and salt intake, in a community
with limited opportunity for increased physical activity,
is paramount and should be undertaken alongside that







p value Age adjusted
odds ratio
(95% CI)
p value Age-sex adjusted
odds ratio (95% CI)
p value Age-sex-smoking-alcohol
use adjusted odds ratio
(95% CI)
p value
BMI (n = 2037)
≥ 30 34.0 (87) 13.8 (245) 4.4 (3.1-6.2) 0.000 3.2 (2.3-4.6) 0.000 3.2 (2.2-4.7) 0.000 2.9 (1.9-4.4) 0.000
>25-29.9 33.6(86) 28.4 (506) 2.1 (1.5-2.9) 0.000 1.7 (1.2-2.4) 0.002 1.7(1.2-2.4) 0.002 1.8(1.2-2.5) 0.003
18.5-25 29.7 (76) 53.0 (943) Ref Ref Ref Ref
<18.5 2.7 (7) 4.8 (85) 1.0 (0.5-2.3) 0.956 1.1 (0.5-2.4) 0.883 1.1 (0.5-2.4) 0.884 1.2 (0.5-2.7) 0.745
Waist Circ. (n = 2032)
Elevated 39.6 (101) 18.9 (335) 2.8 (2.1-3.7) 0.000 2.1 (1.6-2.8) 0.000 2.4 (1.6-3.5) 0.000 2.4 (1.6-3.6) 0.000
Normal 60.4 (154) 81.1 (1440) Ref Ref Ref Ref
Waist Hip Ratio (n 2027)
High 22.0 (56) 12.0 (212) 2.1 (1.5-2.9) 0.000 1.6 (1.1-2.2) 0.012 1.4 (1.0-2.1) 0.074 1.3 (0.8-2.0) 0.273
Normal 78.0 (198) 88.0 (1559) Ref Ref Ref Ref
Diabetes 14.0 (36) 1.7 (30) 9.5 (5.7- 15.7) 0.000 5.1 (3.0-8.7) 0.000 4.9 (2.9-8.5) 0.000 4.4 (2.4-8.3) 0.000
No Diabetes 86.0 (222) 98.3 (1758) Ref Ref Ref Ref
BMI = body mass index. Categories: ≥30 Obese; >25-29.9 Over-weight <18.5 Under-weight.
Waist Circ = Waist Circumference. Categories: Elevated Male >102 cm; Female >88 cm.
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among Africans. This in particular among females who
have a greater burden of obesity and have been shown in
other studies to have a lack of awareness of the presence
and hazards of excess body weight and thus little desire
for change [27].Strengths and limitations
To the best of our knowledge this is among the first
published urban slum NCD survey report from Kenya,
whose strengths and limitations have been discussed in a
related publication. [25]. In brief our strengths include
reported age standardised prevalence, utilising standard
survey methods that allow for comparability across stud-
ies and regions. By sampling an average of 2.4 adults per
household we do not expect that over representation of
family size impacted our results. We acknowledge the
random walk method in household survey as not opti-
mal for obtaining a probabilistic sample. The availability
of dietary data, including salt intake, and socio-
economic and lipid profile data would have strengthened
our findings. The limitations of self reported physical ac-
tivity and the inherent limitation of a cross-sectional
study design in prohibiting causal interpretation are ac-
knowledged. Our instruments standardisation method
for weight and BP, were suited to a field slum study cir-
cumstances, however could have potentially introduced
a non-differential bias. In clinical practice, a diagnosis of
hypertension requires multiple measurements on several
occasions. We took a single occasion measurement and
therefore, the prevalence of hypertension found in our
survey may represent an overestimation.Conclusion
In conclusion the age adjusted prevalence of hyperten-
sion is high, even among the urban poor living in a low
income country, and is significantly correlated with over-
weight and obesity that is not uncommon among this
community. Majority of the hypertensive subjects are
undetected and therefore unaware of the risks they face;
a recognised major impediment to control of hyperten-
sion. This points to the need for greater awareness of
hypertension in the general population and health care
givers. In tandem, within the health system greater em-
phasis needs to be placed on detection, treatment and
control of high blood pressure. Preventive efforts target-
ing behavioural lifestyle changes, at community level, to
curtail these risk factors at population and individual
level is urgently required. Reducing these risk factors will
not only have an effect on hypertension, but will also
have wide-reaching beneficial effects for other chronic
non-communicable diseases.Additional files
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